Skye Bioscience, Inc.
SKYE
$2.23
$0.3518.62%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.87M | 4.74M | 3.43M | 3.91M | 3.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.81M | 12.67M | 14.90M | 13.26M | 18.24M |
| Operating Income | -7.81M | -12.67M | -14.90M | -13.26M | -18.24M |
| Income Before Tax | -10.78M | -12.51M | -14.44M | -12.75M | -17.62M |
| Income Tax Expenses | 3.40K | -- | 0.00 | -- | 3.40K |
| Earnings from Continuing Operations | -10.79M | -12.51M | -14.44M | -12.75M | -17.62M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.79M | -12.51M | -14.44M | -12.75M | -17.62M |
| EBIT | -7.81M | -12.67M | -14.90M | -13.26M | -18.24M |
| EBITDA | -7.65M | -12.50M | -14.72M | -13.09M | -18.06M |
| EPS Basic | -2.17 | -2.52 | -2.91 | -2.57 | -3.56 |
| Normalized Basic EPS | -0.97 | -1.58 | -1.84 | -1.62 | -2.23 |
| EPS Diluted | -2.17 | -2.56 | -2.91 | -2.57 | -3.56 |
| Normalized Diluted EPS | -0.97 | -1.58 | -1.84 | -1.62 | -2.23 |
| Average Basic Shares Outstanding | 4.96M | 4.96M | 4.96M | 4.96M | 4.96M |
| Average Diluted Shares Outstanding | 4.96M | 4.96M | 4.96M | 4.96M | 4.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |